Commentary
The GlaxoSmithKline situation has exposed the issue of corruption in China. This issue of China Watch, prepared by David Mahon, attempts to address corruption in China and the relationship that foreign companies have with it. Click here to read the latest issue of China Watch.
Aug 20, 2013